Skip to main content
. 2020 Mar 27;2(4):258–264. doi: 10.1016/j.cjco.2020.03.010

Table 2.

Effect of treatment on BP, SA, renin, and aldosterone

Variable CPAP therapeutic
CPAP subtherapeutic
P value
Pre Post Pre Post
MSNA bursts/min 47.5 (39-52.3) 49 (35.4-52.4) 40.4 (37.6-52.4) 46 (38.5-53.5) 0.99
MSNA bursts/100 beats 82 (70.9-95.3) 90.3 (69-90.4) 81.4 (72.4-89) 86 (76.9-96.5) 0.99
ABPM SBP awake (mm Hg) 144 (136-153) 136 (133.3-144.3) 138.5 (127.8-146.8) 154 (152-160) 0.045
ABPM DBP awake (mm Hg) 79 (70-88) 73.5 (71-77.8) 73 (67.8-80.3) 83 (72-97) 0.015
ABPM SBP sleep (mm Hg) 135 (124-145) 119 (115.8-134) 132 (124-138.8) 146 (137-167) 0.004
ABPM DBP sleep (mm Hg) 75 (65-83) 65 (56.5-73.8) 68 (63.3-76) 81 (65-87) 0.004
ABPM SBP Overall (mm Hg) 141 (135-150) 133 (130.3-138.8) 136.5 (128.8-145) 153 (148-161) 0.022
ABPM DBP Overall (mm Hg) 80 (69-86) 72.5 (66.5-76.3) 72 (65.8-79) 84 (72-94) 0.012
Heart rate awake (beats/min) 70 (59-79) 67 (58-85) 65 (61-70) 64.5 (57-77) 0.83
Heart rate sleep (beats/min) 66 (45-87) 62 (50-78) 58.5 (51-64) 59.5 (53-70) 0.62
Heart rate overall (beats/min) 69 (59-79) 65 (56-85) 65 (59-68) 63 (56-77) 0.61
Aldosterone (pmol/L) 178.5 (92.8-260.5) 118.5 (76.3-152.5) 98 (82.5-147.3) 103 (89.8-165.8) 0.23
Plasma renin activity (ng/mL/h) 0.55 (0.4-3.33) 1.05 (0.8-2.2) 1.25 (0.73-3.8) 0.4 (0.2-3.7) 0.85
Norepinephrine (pg/mL) 341 (266.5-669) 428 (368.5-794.3) 432 (368.8-478.8) 315 (161.5-554) 0.27
Epinephrine (pg/mL) 32 (16-33.5) 30.5 (13-60.8) 49.5 (10.8-158) 20 (15-53) 0.54
BMI (kg/m2) 30.9 (28.7-34.9) 30.8 (28.6-34.2) 34.2 (32.5-35.7) 34.9 (32.2-36.6) 0.83

All data presented as median (interquartile range). P relates to the effect of treatment (therapeutic vs subtherapeutic CPAP).

ABPM, ambulatory blood pressure monitoring; BMI, body mass index; BP, blood pressure; CPAP, continuous positive airway pressure; DBP, diastolic blood pressure; MSNA, muscle sympathetic nerve activity; SA, sympathetic activity; SBP, systolic blood pressure.